have been subdivided based on differences in major outer membrane protein (OMP) profiles resolved on gradient and modified Laemmli sodium dodecyl sulfate-polyacrylamide gel electrophoresis systems. Although 21 subtypes have been observed, 86% of invasive isolates have one of five common subtypes and 71% of isolates have one of three subtypes. In isolates with two of the most common outer membrane subtypes, one major OMP has an apparent molecular weight of 37,000. In isolates with another common OMP subtype, a cross-reactive protein with an apparent molecular weight of 36,500 is observed. All three proteins have been designated P2. Protein P2 from these prototype isolates was solubilized with Zwittergent 3-14 and purified to homogeneity. Based on amino acid compositions, cyanogen bromide cleavage products, staphylococcal V8 protease, and chymotryptic peptide maps, the P2 protein from the three isolates has been highly conserved. Rabbit antibody prepared against P2 from one strain was cross-reactive with P2 isolated from the other two heterologous strains by Western blot. This antibody passively protected infant rats against type b Haemophilus infection caused by the homologous organism, but not against challenge by a strain with the heterologous 36,500 mol wt P2 protein. Thus, although the P2 protein from isolates with different OMP subtypes are closely related, the protection experiments suggest that determinants on This work was presented in part at the Annual Meeting of the
INTRODUCTION
Haemophilus influenzae type b (Hib)' is a major cause of bacterial meningitis and other invasive infections in young children. Children of the susceptible age lack antibody to the Hib capsular polysaccharide and children under 1 yr of age generally respond poorly to the presently available capsule-based vaccines. In contrast, children of this age group respond vigorously to protein vaccines (1) , and outer membrane proteins (OMP) of this organism appear to be immunogenic during natural infection (2) . Recently, Lam et al. (3) demonstrated that passive administration of antibody directed against noncapsular antigens of Hib-protected infant rats against Hib bacteremia after intraperitoneal challenge. Shenep et al. (4) extended these observations by demonstrating that anti-lipopolysaccharide (LPS) antibodies lacked protective activity. In contrast, antibodies directed against OMP appeared to confer protection. In these experiments, antibodies directed against several OMP were detected in the protective immune sera by whole cell radioimmune precipitation, which suggests that some OMP epitopes on the surface of these encapsulated organisms were accessible to antibody. One protein detected in these preparations was a 37,000-D major OMP designated P2. We report the purification and partial characterization of the major OMP P2 from three strains of Hib that are representative of the previously described OMP subtypes 1H, 2L, and 3L (5) . Antibody prepared against purified P2 from the 1H strain passively protects infant rats against experimental infection when challenged with the organism from which the immunogen was prepared. In contrast, this antibody preparation failed to protect against bacteremia when rats were challenged with the OMP subtype 2L organism.
METHODS
Bacterial isolates. Invasive Hib isolates (from patients with meningitis or bacteremia) were obtained, typed, and stored as previously described (5) . Three prototype isolates, Minn A, b3a (Durst) , and Corn, which are representative of OMP subtypes 1H, 2L, and 3L, were employed in these studies. Isolates were cloned on chocolate agar, and grown overnight at 37°C in a 5% CO2 atmosphere in brain-heart infusion broth (Difco Laboratories, Inc., Detroit, MI) supplemented with 2 8 .0, harvested after 30 min, and then washed once in the same buffer. Protein P2 was then solubilized by suspension of the pellet in 0.4% Zwittergent 3-14 (Calbiochem-Behring Corp., La Jolla, CA) buffered with 25 mM imidazole at pH 6.5. After 30 min, the insoluble fraction was removed by centrifugation at 105,000 g. Triton X-100 (Packard Instrument Co., Inc., Downers Grove, IL) was added to the soluble fraction to a final concentration of 0.5% and the preparation was applied to DEAE-Sephacel equilibrated with 25 mM imidazole, 0.4% Zwittergent 3-14, and 0.5% Triton X-100, pH 6.5. Optimal results were obtained with application of -1 mg of protein/ milliter of DEAE-Sephacel. The column was washed with two column volumes of the same buffer containing 0.05 M KCI and P2 was eluted with a linear gradient of 0.05-0.4 M KCI in the same buffer (total of seven column volumes). P2 was the predominant protein in the sample and eluted as a single peak (Fig. 1) . Protein-containing fractions were assessed for purity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and pooled.
PAGE. SDS-PAGE was carried out in 4-24% gels and in 11% modified Laemmli gels according to the method of Lugtenberg and co-workers, as previously described (5) . These gel systems have previously been used by us to subtype Hib isolates (5) and to examine OMP heterogeneity of nontypable Haemophilus isolates (6) . Chemically and enzymatically digested samples were analyzed on modified Laemmli gels containing 15% polyacrylamide as well as on gradient gels.
Chemical and enzymatic digestions. Cyanogen bromide cleavage of P2 from the different prototype strains was conducted in 70% formic acid (7) . 40-jig aliquots of purified P2 Chymotryptic 125I-peptide maps of purified P2 were prepared by the method of Elder et al. (9) as described by Swanson (10) . Ethanol-precipitated protein (40 Mg) was solubilized with 1% SDS, 0.1 M Tris-Cl, pH 6.8, at 100°C for 5 min. Samples were iodinated with chloramine T and quenched with Laemmli sample buffer containing 5% f3-mercaptoethanol. Free iodine was removed by SDS-PAGE employing the modified Laemmli system. Stained proteins were cut out of the gel, washed with 10% methanol, treated with N-p-tosyl-L-lysine chloromethyl ketone-treated chymotrypsin, and analyzed as previously described (10) .
Analytical techniques and reagents. Protein was determined by the method of Lowry as modified by Peterson (11) employing bovine serum albumin (BSA) as the standard. Amino acid analysis was performed on a Durrum D-500 analyzer ( Anticapsular antibody in these sera was determined by radioimmune assay using 3H-labeled Hib capsule as described by Kuo and co-workers (12) . Anti-LPS and anti-P2 antibodies were quantitated by enzyme-linked immunosorbent assay (ELISA) (13) . For measurement of anti-LPS antibody, LPS was prepared from the Minn A isolate by the hot phenol method and characterized as described previously (13) . For measurement of anti-P2 antibody, purified P2 was precipitated with ethanol to remove detergent, suspended in PBS, and diluted to 2 Mg/ml in carbonate coating buffer at pH 9.6. EIA plates (Flow Labs, Inc., McLean, VA) were coated with LPS or P2 overnight at 37°C. The following day, assays were performed as described by Shenep et al. (13) , using a goat anti-rabbit IgG-alkaline phosphatase conjugate (Sigma Chemical Co.). Western blot analysis was performed as described by Towbin et al. (14) .
Anti-LPS and anti-polyribosyl-ribitol phosphate (PRP) antibodies were removed from anti-P2 antisera by absorption with LPS-Sepharose and PRP-Sepharose, respectively. LPS-Sepharose preparation and antibody absorptions were performed as previously described (13) . For preparation of PRP-Sepharose, PRP was purified from the supernatant of stationary phase broth cultures by sequential precipitation with ethanol, Cetavlon, and ethanol, as described by Kuo and co-workers (12) . The final PRP precipitate was dissolved in 20 mM sodium phosphate, pH 6.9, and residual contaminants were removed by absorption with hydroxylapatite. Protein and nucleic acid content of the final product (2 and 0.7%, respectively) were determined by UV absorption (15) . LPS content of the final product was <0.06% by limulus lysate gelation. PRP-Sepharose was prepared by coupling cyanogen bromide-activated PRP to w-aminohexyl-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) using methods similar to those of Robbins and Schneerson (16) . PRP (3.0 mg in 1 ml of water) was activated by treatment with 46 mg of cyanogen bromide (1 ml) at room temperature while the pH was maintained at 10.8 with sodium hydroxide. After 10 min, 1 ml of 0.1 M NaHCO3 was added and the solution was brought to pH 8.3 with HCI. 1 g of w-aminohexyl-Sepharose, that had been previously swollen and washed in 0.1 M NaHCO3, was added and incubation continued overnight at 40C with gentle mixing. Residual reactive groups were blocked with ethanolamine at pH 8.0 and the product was washed extensively with PBS. Antisera were absorbed with PRP-Sepharose for 2 h at room temperature with gentle agitation. After collection of the unabsorbed fraction, the PRP-Sepharose was washed extensively with PBS containing 0.5% BSA. Affinity pure anti-PRP was eluted from the column with 3.5 M MgCl2, diluted immediately with 1 vol of PBS-albumin, and dialyzed against PBS. Anti-PRP antibody was determined by radioimmune assay as described above.
Experimental infection. 5-d-old infant rats were injected subcutaneously with 0.1 ml of dilutions of serum antibody fractions or PBS-albumin. 1 d later, animals were challenged with 102 to 103 Hib colony forming units (cfu) by intraperitoneal injection as described by Lam et al. (3) . Quantitative bacterial cultures of blood were obtained 18 h later as previously described (3).
RESULTS
The major OMP of Hib are Triton X-100-insoluble (3, 5, 17) and sarcosyl-insoluble (5), as are the OMP of other gram-negative organisms (18, 19) . Unlike proteins from enteric microorganisms, however, treatment of whole cells or total membrane preparations of Hib with 2% SDS at 60°C (20) Fig.  2 . The final preparation appeared to be homogenous by SDS-PAGE (Fig. 2) .
LPS, an outer membrane glycolipid which is frequently detectable in OMP preparations (20) , was determined by limulus lysate analysis in two independent P2 preparations. One contained 1.1% and the other 3.3% LPS by weight.
We have previously demonstrated strain heterogeneity among the major Hib OMP of isolates of Hib. OMP profiles of prototype isolates that represent the three most common subtypes are shown in Fig. 3 . When examined on the modified Laemmli gel, protein P2 from subtype 2L isolates has a slightly lower apparent molecular weight (36,500) than that of the corresponding protein in outer membrane preparations from subtype 1H and 3L organisms, which have an apparent molecular weight of 37,000. This difference is more apparent in the 4-24% gradient gel (Fig. 3) . To further compare P2 from the prototype strains, we purified this protein from each strain as described above. In all preparations, the differential detergent solubilities and DEAE-elution profiles were similar.
The cleavage pattern, and peptide maps of the three proteins were then compared. The amino acid composition of the proteins is shown in Table I and is similar (Fig.  4) . The lower apparent molecular weight of P2 from the OMP subtype 2L strain is reflected in a lower apparent molecular weight of the largest cleavage product. Purified P2 proteins were also treated with staphylococcal V8 protease according to the method of Cleveland (8) and examined by SDS-PAGE (Fig. 5 ).
Increased digestion times or increased protease concentrations resulted in further degradation of the large peptide into poorly resolved low molecular weight peptides (data not shown). To increase the resolution of the peptide maps, we iodinated the purified proteins by the chloramine T technique and examined the chymotryptic peptides by thin-layer electrophoresis and chromatography. Autoradiographs of the iodinated peptides are shown in Fig. 6 . As in the previous analysis, the three proteins gave similar cleavage products. Antibody to purified P2 (subtype 1H) was prepared by immunization of rabbits with antigen emulsified in Freund's adjuvant. Hyperimmune serum contained antibody directed against both Hib LPS and P2, as measured by ELISA (Table II) . After absorption of anti-LPS antibody with LPS-Sepharose (13), the specificity of anti-P2 antibody was determined by Western blot using total membrane proteins from the prototype isolates as the antigens. This antiserum reacted exclusively with P2; therefore, antibodies directed against FIGURE 4 40 ug of purified P2 from each of the prototype strains was treated with 2. other membrane proteins were not detected (Fig. 7 , lane 1). However, P2 from the other prototype strains cross-reacted extensively by this method (Fig. 7, lanes  2 and 3) . OMP have been considered as potential vaccine candidates for the prevention of diseases caused by Haemophilus (3, 23) and other gram-negative bacteria (24, 25) . Therefore, anti-P2 antibody was examined for its ability to protect infant rats from Hib bacteremia. Sera were absorbed sequentially with PRP-Sepharose and LPS-Sepharose. Adequacy of absorption of anti-PRP and anti-LPS antibodies was monitored by radioimmune assay and ELISA, respectively (Table II) . A 1:2 dilution of anti-P2 antiserum protected six of seven infant rats that were challenged with the homologous Hib strain Minn A (subtype 1H), and a 1:8 dilution completely protected three of seven rats and significantly lowered the level of bacteremia in the remaining four animals (Table III) . Surprisingly, the same serum fraction did not protect against challenge by a heterologous Hib strain, Durst, our prototype OMP subtype 2L isolate; six of seven animals were bacteremic at the 1:2 dilution (Table IV) . Affinity-purified anti-PRP antibody, which was previously shown to protect infant rats against Hib bacteria, protected seven of seven rats challenged with strain Minn A, and six of six rats challenged with strain Durst (Tables III  and IV, FIGURE 6 Chymotryptic peptide maps of P2, iodinated with chloramine T, were prepared from each of the prototype strains. Peptides were separated by thin-layer electrophoresis (TLE) which was followed by thin-layer chromatography (TLC). Peptides were visualized by autoradiography. Preparations from the 1H, 2L, and 3L strains are shown in panels a, b, and c, respectively.
tions. In previous experiments, anti-P2 antibody was detected in hyperimmune whole cell antisera containing non-PRP, non-LPS antibodies that protected against 2L isolates and one of five independent OMP 3L isolates were also strongly fluorescent. Thus, although the P2 proteins from isolates with different OMP subtypes are closely related, the cross protection and immunofluorescence experiments indicate that P2 determinants that are exposed on the cell surface and interact with protective antibody are to a large extent OMP subtype or strain specific. Similarly, antiserum prepared against whole cells (strain Eagan, OMP subtype 1L) and absorbed to remove anti-PRP and anti-LPS antibody was previously shown by us to protect infant rats challenged with the homologous strain, Eagen (4), as well as to protect against bacteremia caused by another randomly chosen OMP subtype IL organism (unpublished data). However, this antiserum failed to protect against bacteremia caused by strain Durst, the strain with OMP subtype 2L (4).
Hansen and co-workers (23) have recently demonstrated that monoclonal antibody directed against an OMP with an apparent molecular weight of 39,000 protected infant rats against Hib bacteremia. In these experiments, protection was also shown to be strain specific. The monoclonal antibody used by Hansen et al. (23) has recently been found by us to react with protein P2 in 18 of 21 invasive subtype 3L isolates tested, but in none of 36 subtype IL, 1H, 2L, and 2H isolates examined to date (unpublished data). Thus, data from experiments using both monoclonal antibody and conventional antisera indicate that protein P2 with an apparent molecular weight estimated between 37,000 and 39,000 (23) is an effective immunogen in eliciting strain-specific protective anti-OMP antibody in both mice and rabbits. Furthermore, P2 purified by solubilization with Zwittergent retains strain-specific immunogenic surface determinants responsible for eliciting protective antibody. These data support the value of continued investigations of the role of OMP in inducing immunity against Hib disease Protective Antibodies to Haemophilus influenzae in humans and the possible, eventual inclusion of OMP in prototype vaccines for human use.
